✦ LIBER ✦

Membrane tumor necrosis factor receptors in lung and kidney of malnourished rats

✍ Scribed by Nilima Raina; Khursheed N. Jeejeebhoy

Book ID: 119424384
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 187 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(00)80232-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor Necrosis Factor Receptors: Biology

Tumor Necrosis Factor Receptors: Biology and Therapeutic Potential in Kidney Diseases

✍ Speeckaert, Marijn M.; Speeckaert, Reinhart; Laute, Margo; Vanholder, Raymond; D 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 300 KB

Pharmacokinetics and catabolism of tumor

Pharmacokinetics and catabolism of tumor necrosis factor-α in rat lungs

✍ Gian Paolo Pessina; Luana Paulesu; Fausto Corradeschi; Enrico Luzzi; Carlo Aldin 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 474 KB

Tumor necrosis factor receptor 2 mRNA in

Tumor necrosis factor receptor 2 mRNA in rat models of hypertension

✍ Ruby C.Y Lin; Chris G Schyvens; Yi Zhang; Judith A Whitworth; Brian J Morris 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 128 KB

Induction of tumor necrosis factor recep

Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-α in rat primary astrocytes

✍ H.L. Lung; K.N. Leung; A. Stadlin; C.M. Ma; D. Tsang 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Immunolocalization of Tumor Necrosis Fac

Immunolocalization of Tumor Necrosis Factor Receptor–Associated Factor 6 in Rat Periapical Lesions

✍ Lijie Yang; Chi Zhang; Bin Peng 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 346 KB

Prognostic significance of tumor necrosi

Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma

✍ Tien-Anh Tran; Bhaskar V. S. Kallakury; Robert A. Ambros; Jeffrey S. Ross 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 2 views

## BACKGROUND. In vitro studies have shown an antiproliferative effect of tumor necrosis factor (TNF) against various nonsmall cell lung carcinoma (NSCLC) cell lines. However, clinical trials of combined interleukin-2 and TNF-␣ in patients with advanced NSCLC have demonstrated both conflicting and